◆A paper by the research team led by Specially Appointed Professor Eiki Sano has been published in the *Journal of Cutaneous Immunology and Allergy*
Release Date:
A paper by a research team led by Assistant Professor Mayuko Yamamoto and Specially Appointed Professor Eiki Sano of the Department of Dermatology at Kochi University School of Medicine has been published in Wiley’s online journal *Journal of Cutaneous Immunology and Allergy*.
In Japan, more than 80% of the population has completed their second dose of the COVID-19 mRNA vaccine, which was introduced in 2021; however, numerous reports of various side effects, including skin reactions, have been received.
Professor Eiki Sano and his team examined the rash sites of patients who developed skin symptoms following vaccination and detected the COVID-19 spike protein (*). This finding suggests that the spike protein encoded by the mRNA may be involved in the skin pathology as a side effect of the vaccine.
Although this study focused on the skin, if we can demonstrate the same results for the spike protein expressed in other organs, it could provide evidence of organ-specific side effects caused by mRNA vaccines.
Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of the encoded spike protein in the lesion
The spike protein encoded by the vaccine mRNA was detected in the rash areas of patients with persistent varicella-zoster virus infection that developed following COVID-19 vaccination
*Spike protein: A protein on the surface of a virus that has a spike-like shape